Small Molecule API CDMOs

EnBridge PharmTech is a Chinese pharmaceutical company founded in 2013 in Wuxi, offering CRO and CDMO services for pharmaceutical intermediates and APIs. The company operates an R&D center and a GMP-compliant manufacturing base with large-scale reactors capable of high pressure, high temperature, and low temperature reactions, exporting to the USA, Japan, India, and Europe.

Excella GmbH & Co. KG, now part of the Fareva Group, is a German CDMO that has served the pharmaceutical industry for more than 35 years specializing in high-quality API manufacturing. The company is located in Feucht near Nuremberg, Germany, and focuses on active pharmaceutical ingredient development and production.

F.I.S. (Fabbrica Italiana Sintetici) is a privately owned Italian CDMO operating since 1957, specializing in the development and production of APIs and cGMP intermediates for the global pharmaceutical industry. The company offers contract development and manufacturing services including HPAPI production up to OEB3 containment from multiple production plants.

Fuxin Jintelai Fluorine Chemical Co., Ltd. is a Chinese manufacturer of fluorine-containing pharmaceutical and pesticide intermediates, established in 2001. The company is located in the Fluorine Industry Development Zone of Fuxin, Liaoning, covering 30,000 sqm with 16 series and over 500 product variants. It is ISO-certified and exports to Japan, Europe, the US, and India.

Jubilant Ingrevia Ltd

India

Jubilant Ingrevia is a global leader in life science ingredients and specialty chemicals, listed as a Jubilant Bhartia Group company. Core businesses: specialty chemicals (pyridine, picolines, fine chemicals, agrochemicals), nutrition & health solutions, and chemical intermediates (acetyls, specialty ethanol). They have a CDMO division (currently non-GMP per investor presentation) for custom synthesis and contract manufacturing of intermediates and fine chemicals. Website explicitly mentions CDMO services but the CRISIL report notes it is 'CDMO (Non-GMP)'. Primarily a chemical intermediates and ingredients manufacturer with a nascent pharma CDMO arm.

Kirsch Pharma HealthCare GmbH is a German company focused on pharmaceutical raw materials sourcing and production, and production technologies (refining and mixing). Their website indicates services in pharmaceutical sourcing and production of raw materials. A related entity, Kirsch BioPharm, appears to be building biopharma manufacturing capabilities, but Kirsch Pharma HealthCare itself is primarily a pharmaceutical raw material and excipient supplier rather than a CDMO. Without website text or detailed evidence of contract drug manufacturing, they are classified as a raw material supplier.

Macsen Laboratories

India

Macsen Laboratories (N.K Agrawal Group), a chemical manufacturing organization with origins dating back to 1952, manufactures niche Active Pharmaceutical Ingredients, pharmaceutical application dyes, and specialty chemicals. They are the world's only cGMP manufacturer of a complete range of pharma application and injectable dyes. They specialize in cGMP manufacturing of niche, atypical, and rare-to-find APIs and also offer custom synthesis/contract research services. FDA-registered with FEI for API manufacturing. They are building a new API manufacturing facility to expand CDMO capabilities.

Prayog Life Sciences (also referred to as NSJ Prayog Life Sciences Pvt Ltd) is an Indian company established in 2018, listed on PharmaSource as providing contract manufacturing (CMO/CDMO), packaging, formulation development, process development, and analytical services. On CPHI Online they describe providing services for process optimisation and development of APIs along with their intermediates. Limited web presence with no website content available.

Juzen Chemical (Japanese: ten-zen kagaku) is a Japanese CDMO/CMC company specializing in active pharmaceutical ingredient and intermediate manufacturing. GMP-compliant quality standards with diverse synthesis technologies. Offers both small molecule and oligonucleotide API synthesis/manufacturing. Toyama-based manufacturing. This is the Japanese-language entry for the same company as Juzen Chemical Corp (English site). FDA registered with 1 FEI number for API manufacture.

Juzen Chemical Corporation (English name for the same entity as Juzen Chemical) is a Japanese CDMO providing contract manufacturing of APIs and intermediates plus CMC solution services. GMP-compliant with diverse synthesis technologies. Offers oligonucleotide pharmaceutical services (synthesis, development, GMP manufacturing) and small molecule contract manufacturing. Multiple manufacturing plants (JPP-I, JPP-II, JPP-III, JHP) and pilot plant. FDA registered with 2 FEI numbers, 7 inspections (3 NAI, 4 VAI, 0 OAI).

Chinese pharmaceutical company (subsidiary of Nanjing Pharmaceutical Co., Ltd.) focused on R&D, manufacturing, and marketing of APIs and formulations primarily in nephrology. Key products include Iron Sucrose Injection, Compound alpha-Ketoacid Tablets, Sevelamer Carbonate Tablets, and Phloroglucinol Injection. Listed as a small molecule API CMO in industry directories. FDA registered with 2 FEI numbers. Not primarily a contract manufacturer -- manufactures and sells own branded products, but listed in CMO directories.

Louston International Inc. is a technology-driven organization with facilities in Philadelphia (USA), Beijing, Tianjin, and Shijiazhuang (China). They specialize in developing, manufacturing, and marketing fine chemical intermediates and APIs through two commercial sites in China. FDA-registered with FEI for API manufacturing and analysis.